Role of fructose in obesity, a new perspective
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.
Drugs
Health
Medical
Drugs
Health
Medical
Innovative magnetic gel accelerates diabetic wound healing
HQ Team October 20, 2023: More than half a billion people worldwide are living with diabetes, and this number is expected to rise..
Drugs
Health
Medical
Some children may outgrow autism spectrum disorder: Study
HQ Team October 12, 2023: A recent study conducted by Boston Children’s Hospital found that more than a third of toddlers diagnosed with.
Health
Medical
Pharma
US drug regulator ‘unsatisfied’ by Philips’s progress on ventilator recall
HQ Team October 6, 2023: Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA.
Drugs
Health
Medical
Walkable environs cut risk of obesity-related cancers in women
HQ Team October 5, 2023: A new study by Columbia University Mailman School of Public Health and NYU Grossman School of Medicine says.
Health
Medical
Pharma
Opinion: Dr K Leelamoni on dengue prevention, surveillance in India
October 3, 2023: Limna Purushan, 46, works as a domestic helper in my home in Kochi. She has been saving up all her.
Health
Medical
Pharma
Cordis acquires medical device maker MedAlliance for $1.1 billion
HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.
Health
Medical
Pharma
India unveils steps to grow drug industry to $130 billion in 10 years
HQ Team September 27, 2023: India, the third-largest pharmaceutical industry in the world by volume, has unveiled a policy to make the South.
Health
Medical
Pharma
Amazon teams up with Anthropic, invests $4 billion for stake
HQ Team September 26, 2023: Amazon is investing $4 billion to take up an unspecified minority stake in artificial intelligence systems company Anthropic..
Health
Medical
Pharma
Elon Musk’s Neuralink Corp gets nod to begin human trials
HQ Team September 20, 2023: Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a.